Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
The current Merck(MRK) stock price is $98.77, with a market capitalization of 245.62B. The stock trades at a price-to-earnings (P/E) ratio of 13.19 and offers a dividend yield of 3.2%.
During the trading session on 2025-12-09, Merck(MRK) shares reached a daily high of $99.84 and a low of $97.81. At a current price of $98.77, the stock is +1.0% higher than the low and still -1.1% under the high.
Trading volume for Merck(MRK) stock has reached 12.9M, versus its average volume of 14.99M.
Over the past 52 weeks, Merck(MRK) stock has traded between a high of $105.84 and a low of $73.31.
Over the past 52 weeks, Merck(MRK) stock has traded between a high of $105.84 and a low of $73.31.
MRK News
The Fed just reminded everyone that the path to lower rates won't be a straight line. In late October, policymakers delivered a second cut this year. The benchm...
(RTTNews) - Merck & Co., Inc. (MRK), known as MSD outside the U.S. and Canada, announced Monday that the province of Saskatchewan has added CAPVAXIVE, a 21-vale...
Merck (MRK) has been in the spotlight after a cluster of investor friendly moves, from a higher dividend and fresh drug approvals to upbeat Wall Street commenta...
Analyst ratings
52%
of 27 ratingsMore MRK News
With yields between 3.4% and 6.8%, you'll need to think carefully about the highest yields in the Dow before you buy them. Just because a stock offers a high y...
Wondering if Merck at around $100 a share still looks attractive or if the easy gains are behind it? This breakdown outlines key considerations to help you asse...
Key Points Pfizer has a sizable 6.8% yield and is down nearly 60% from its 2021 highs. Bristol Myers Squibb has a 5% yield and is off its 2023 highs by nearly...
Key Points Merck's newest acquisition could help it launch a promising flu candidate. Several other ongoing developments are helping paint a bright post-Keytr...
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...
The ruling applies only to the subcutaneous formulation of the Rahway, N.J., company’s treatment, rather than the intravenous formulation, which Halozyme said i...
Pliant Therapeutics, Inc. (NASDAQ:PLRX) is capturing attention with promising trial results for its cancer therapy, despite a sharp stock decline. PLRX stock i...